This study is testing if a medication called varenicline (Chantix) can help people stop using e-cigarettes. You might be able to join if you are an adult, use e-cigarettes daily, and live in Connecticut or South Carolina. You cannot join if you use other tobacco products, have certain medical conditions, or are already getting treatment to quit tobacco. Participants will either receive varenicline or a placebo (an inactive pill that looks like the study drug) for 12 weeks, along with counseling. The main goal is to see how many people successfully quit e-cigarettes by week 12. The current status of this study is unclear.

Study design

This is a randomized, placebo-controlled study, meaning participants are randomly assigned to receive either varenicline or a placebo. The study plans to enroll 326 participants.

What's involved

You would take varenicline or placebo for 12 weeks. You will also have research assessments every 3 weeks during treatment.

Compensation

Not stated in the trial record.

Follow-up

There will be a final follow-up visit at week 26, which is 14 weeks after the treatment period ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.